nateglinide
英 [nə'teɡlaɪnaɪd] 美 [nə'teɡlaɪnaɪd]

释义

[医]那格列奈，那格列胺；

权威例句

Nateglinide.
Repaglinide versus nateglinide monotherapy: a randomized, multicenter study
Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.
Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure.
Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia
Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.
PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin
Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naive patients with type 2 diab...
Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.